Delenex Therapeutics

Delenex Therapeutics

Delenex Therapeutics

Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.
Founded
2009
Raised
$8M
Follow us
Alexa global traffic share
Latest funding
$8,000,000
Venture capital (Series A) - 2013
Team Size
2
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Delenex Therapeutics makes some noise.